Both in Biotechnology
MeiraGTx Holdings vs Prime Medicine
Over the past year MGTX returned +4.5% and PRME returned −4.5%; their daily moves had a correlation of 0.41.
MGTX +4.5% PRME −4.5%Growth of $1, one year, split-adjusted
| Metric | MGTX | PRME |
|---|---|---|
| Price | $9.49 | $4.72 |
| Market cap | $911.4M | $856.1M |
| Today | −2.22% | −9.92% |
| 1 month | −11.0% | +57.9% |
| 6 months | +0.9% | +38.4% |
| Year to date | +19.4% | +36.0% |
| 1 year | +6.3% | +4.0% |
| Revenue growth (YoY) | +8608.6% | +3.5% |
| Gross margin | 97.8% | 100.0% |
| Net margin | 50.0% | −3649.0% |
| P/E (TTM) | 11.5× | — |
| Price / sales | 2.3× | 210.2× |
| Net cash | $21.8M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | 47.5% | 111.1% |
| Short % of float | 10.8% | 34.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).